Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStm Grp. Regulatory News (STM)

  • This share is currently suspended. It was suspended at a price of 61.50
  • There is currently no data for STM

Trading Update

30 Nov 2020 07:00

RNS Number : 8397G
STM Group PLC
30 November 2020
 

 

STM Group Plc

("STM" or "the Company" or "the Group")

Trading Update

 

STM, the cross-border financial services provider, today provides the following update on trading for the year ended 31 December 2020, and expectations for 2021 and beyond.

 

In line with current market expectations, the Board continues to expect the Group will deliver revenue of £23.7 million, EBITDA of £3.6 million, and £2.0 million profit before tax for the year to 31 December 2020.

 

The strong recurring revenue base from exisiting business gives the foundation for our future growth and profitability and remains predominantly unchanged despite the significant macro-economic challenges.

 

As part of the 2021 budget planning cycle, the Board has now taken the decision to adopt a more prudent methodology to its guidance for the year ending 31 December 2021 ("FY21") and beyond. This is set against a backdrop of on-going Covid-19 pandemic concerns, as well as very low interest rates and uncertainty in the financial markets. This has resulted in a number of changes to the assumptions being made, predominantly around new business.

 

The predictability and long-standing history of the QROP and company & trust businesses has meant that there are minimal changes to the Board's expectations of performance for these segments. Similarly, the Board has not changed its expectations for the auto-enrolment and flexible annuity products.

 

This revised approach primarily affects the level of new business for our life assurance and SIPP products.

 

In relation to the life assurance businesses, we have made the decision to not include any new policies from EU member states as a result of the continuing uncertainty surrounding Brexit, and what, if any, passporting rights Gibraltar will have after 2020 year-end. In addition, the Board has now assumed that no new short-term life annuities should be included in the Group's FY21 and FY22 expectations given these products are difficult to predict due to their long lead time. This is especially so in the current economic environment although the opportunity and product remain viable.

 

The Board has also now concluded that it would not be prudent to include any growth in the new business run rate for our expatriate SIPP revenue. Similarly, the Board is now assuming new UK SIPP business will be limited to current partnerships and introducers only, with a measured new business volume being generated by them and assuming no revenue from known but as yet untested partnerships.

 

Finally, the IT investments, as well as the acquisition accounting exercise carried out as per IFRS 3 on the Berkeley Burke acquisition earlier in the year, has resulted in an increased amortisation charge, a non-cash item that directly impacts our statutory profit before tax result.

 

We therefore now anticipate revenue growth of circa 7% for FY21 year-on-year, whilst operating expenses are only forecasted to increase marginally and thus enhanced EBITDA margins will be delivered. The improved EBITDA margin is largely as a result of both direct savings and increased operational efficiencies on the back of the IT projects invested in during the year. Further investment is expected in this area which has been reflected in the Board's revised financial expectations.

 

Alan Kentish, CEO of STM Group commented:

 

"The prolongued nature of the Covid-19 pandemic has had a more significant impact than we previously anticipated. This is frustrating but does not greatly affect the strong core existing business which gives us reliable revenue visibility and a stable long term platform to operate from.

 

"In light of previous challenges around new business, the Board has used the 2021 planning cycle to take a more prudent approach to our forward guidance, given the Covid-19 backdrop, Brexit and the various challenges faced by our introducer base.

 

"Notwithstanding the more prudent approach taken, we are confident in a step-change in profit growth for 2021, albeit from the lower rebased profit position for 2020. STM has a stable business model and a strong balance sheet so these short-term challenges, while unwelcome, require that we adjust our timescale not our ambition."

 

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

 

For further information, please contact:

STM Group Plc

www.stmgroupplc.com

Alan Kentish, Chief Executive Officer

Tel: Via Walbrook

Therese Neish, Chief Financial Officer

 

 

 

finnCap

www.finncap.com

Matt Goode / Emily Watts - Corporate Finance

Tim Redfern / Richard Chambers - ECM

Tel: +44 (0) 20 7220 0500

 

 

Walbrook

www.walbrookpr.com

Tom Cooper / Paul Vann

Tel: +44 (0) 20 7933 8780

 

Mob: +44 (0) 797 122 1972

 

tom.cooper@walbrookpr.com

 

 

Notes to editors:

 

STM is a multi-jurisdictional financial services group which is listed on the AIM Market of the London Stock Exchange. The Group specialises in the administration of client assets in relation to retirement, estate and succession planning and wealth structuring.

 

Today, the Group has operations in the UK, Gibraltar, Malta, Jersey and Spain. STM has developed a range of pension products for UK nationals and internationally domiciled clients and has two Gibraltar Life Assurance Companies which provide life insurance bonds - wrappers in which a variety of investments, including investment funds, can be held.

 

STM's growth strategy is focussed on both organic initiatives and strategic acquisitions.

 

Further information on STM Group can be found at www.stmgroupplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFZMZMLLVGGZM
Date   Source Headline
10th Jul 20172:32 pmRNSHolding(s) in Company
10th Jul 201711:21 amRNSHolding(s) in Company
4th Jul 20174:07 pmRNSDirector/PDMR Shareholding
26th Jun 201710:16 amRNSHolding(s) in Company
24th May 201712:18 pmRNSResult of AGM
24th May 20177:00 amRNSAGM Statement
26th Apr 20177:00 amRNSAnnual Financial Report & Notice of AGM
14th Mar 20177:00 amRNSFinal Results
9th Mar 20177:00 amRNSBudget Changes
13th Feb 201711:39 amRNSPurchase of shares by EBT
6th Feb 20172:04 pmRNSDirector/PDMR Shareholding
12th Jan 20177:00 amRNSTrading Update & Notice of Results
22nd Dec 20167:00 amRNSDirectorate Change
21st Nov 201611:20 amRNSHolding(s) in Company - Replacement
14th Nov 20162:48 pmRNSHolding(s) in Company
11th Nov 20162:14 pmRNSDirector/PDMR Shareholding
25th Oct 20167:00 amRNSUpdate on QROPS pricing model
21st Oct 20167:00 amRNSCompletion of Acquisition of London & Colonial
17th Oct 20167:00 amRNSNew Products Update
22nd Sep 20169:45 amRNSPDMR Shareholding
13th Sep 20167:01 amRNSAcquisition of UK SIPP business
13th Sep 20167:00 amRNSHalf-year Report
9th Aug 20167:00 amRNSPensions trading & pricing strategy update
15th Jul 20162:18 pmRNSHolding(s) in Company
13th Jul 20167:00 amRNSTrading & Corporate Update and Notice of Results
18th May 20162:54 pmRNSResult of AGM
4th May 201611:11 amRNSBoard Changes
13th Apr 201610:40 amRNSAnnual Financial Report & Notice of AGM
1st Apr 201610:30 amRNSHolding(s) in Company
31st Mar 20163:57 pmRNSHolding(s) in Company
1st Mar 20167:00 amRNSFinal Results
29th Jan 201612:00 pmRNSDirector Disclosure
19th Jan 20167:00 amRNSDirectorate Change, Trading Update & Results Date
1st Sep 20157:03 amRNSInterim Results
10th Aug 20157:00 amRNSNotice of Results
8th Jul 201510:15 amRNSSTM Jersey Acquittal & JFSC Public Statement
1st Jul 20157:00 amRNSDirectorate Change
29th Jun 20157:00 amRNSSTM Jersey Acquittal
19th Jun 20151:57 pmRNSChange of Shareholding
15th Jun 20158:55 amRNSHolding in Company
22nd May 20157:00 amRNSHolding in Company
21st May 20157:00 amRNSDirector Dealings
13th May 201512:01 pmRNSResult of AGM
13th May 20157:00 amRNSAGM Trading Statement
22nd Apr 20157:00 amRNSIssue of Equity/TVR
16th Apr 20157:00 amRNSCLN Update & Issue of Equity
2nd Apr 20157:07 amRNSHolding(s) in Company
2nd Apr 20157:06 amRNSHolding(s) in Company
2nd Apr 20157:05 amRNSHolding(s) in Company
2nd Apr 20157:00 amRNSUpdate on Holding in Co - STM Fiduciaire - AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.